Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection

Human Immunology

Volumn 73, Issue 12, 2012, Pages 1282-1286

  Dragun, Duska ^a   Catar, Rusan ^a   Kusch, Angelika ^a   Heidecke, Harald ^b   Philippe, Aurélie ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CellTrend GmbH Luckenwalde   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; COMPLEMENT COMPONENT C4D; HLA ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN SUBCLASS; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD CLOTTING; CHRONIC GRAFT REJECTION; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; INFLAMMATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; PROTEIN BINDING; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84869071750     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.010     Document Type: Article

References (55)

1. Ahern A.T., Artruc S.B., DellaPelle P., Cosimi A.B., Russell P.S., Colvin R.B., et al. Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation 1982, 33(1):103-106.
2. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005, 365(9470):1570-1576.
3. Dragun D., Muller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl. J. Med. 2005, 352(6):558-569.
4. Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation 2008, 86(8):1019-1025.
5. Rosenbaum D.M., Rasmussen S.G., Kobilka B.K. The structure and function of G-protein-coupled receptors. Nature 2009, 459(7245):356-363.
6. Fredriksson R., Lagerstrom M.C., Lundin L.G., Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 2003, 63(6):1256-1272.
7. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454(7201):183-187.
8. Bourne H.R., Meng E.C. Structure. Rhodopsin sees the light. Science 2000, 289(5480):733-734.
9. Jaakola V.P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y., Lane J.R., et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, 322(5905):1211-1217.
10. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318(5854):1258-1265.
11. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450(7168):383-387.
12. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454(7203):486-491.
13. Unal H., Jagannathan R., Bhat M.B., Karnik S.S. Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor. J. Biol. Chem. 2010, 285(21):16341-16350.
14. Standfuss J., Edwards P.C., D'Antona A., Fransen M., Xie G., Oprian D.D., et al. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 2011, 471(7340):656-660.
15. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 2000, 52(3):415-472.
16. Elton T.S., Martin M.M. Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor. Trends Endocrinol. Metab. 2003, 14(2):66-71.
17. Arsenault J., Lehoux J., Lanthier L., Cabana J., Guillemette G., Lavigne P., et al. A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity. Pharmacogenet. Genomics 2010, 20(6):377-388.
18. Mogi M., Iwai M., Horiuchi M. New insights into the regulation of angiotensin receptors. Curr. Opin. Nephrol. Hypertens. 2009, 18(2):138-143.
19. Spiering W., Kroon A.A., Fuss-Lejeune M.M., Daemen M.J., de Leeuw P.W. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000, 36(3):411-416.
20. van Geel P.P., Pinto Y.M., Voors A.A., Buikema H., Oosterga M., Crijns H.J., et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000, 35(3):717-721.
21. Lajemi M., Labat C., Gautier S., Lacolley P., Safar M., Asmar R., et al. Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J. Hypertens. 2001, 19(3):407-413.
22. Jones A., Dhamrait S.S., Payne J.R., Hawe E., Li P., Toor I.S., et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003, 42(4):500-506.
23. Diez J., Laviades C., Orbe J., Zalba G., Lopez B., Gonzalez A., et al. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives. J. Hypertens. 2003, 21(11):2085-2092.
24. Cameron V.A., Mocatta T.J., Pilbrow A.P., Frampton C.M., Troughton R.W., Richards A.M., et al. Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension 2006, 47(6):1155-1161.
25. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jupner A., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 1999, 103(7):945-952.
26. Miura S., Kiya Y., Kanazawa T., Imaizumi S., Fujino M., Matsuo Y., et al. Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol. Endocrinol. 2008, 22(1):139-146.
27. Noda K., Saad Y., Kinoshita A., Boyle T.P., Graham R.M., Husain A., et al. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J. Biol. Chem. 1995, 270(5):2284-2289.
28. Riemekasten G., Philippe A., Nather M., Slowinski T., Muller D.N., Heidecke H., et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann. Rheum. Dis. 2011, 70(3):530-536.
29. Fu M.L., Herlitz H., Schulze W., Wallukat G., Micke P., Eftekhari P., et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J. Hypertens. 2000, 18(7):945-953.
30. Reinsmoen N.L., Lai C.H., Heidecke H., Haas M., Cao K., Ong G., et al. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 2010, 90(12):1473-1477.
31. Colvin R.B. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J. Am. Soc. Nephrol. 2007, 18(4):1046-1056.
32. Hunyady L., Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 2006, 20(5):953-970.
33. Dzau V.J. Theodore cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001, 37(4):1047-1052.
34. Dragun D. Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology. Nephrol. Dial Transplant 2007, 22(7):1819-1822.
35. Mellor A.L., Munn D.H. Immunology at the maternal-fetal interface. Lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 2000, 18:367-391.
36. Saadi S., Takahashi T., Holzknecht R.A., Platt J.L. Pathways to acute humoral rejection. Am. J. Pathol. 2004, 164(3):1073-1080.
37. Dobado-Berrios P.M., Lopez-Pedrera C., Velasco F., Cuadrado M.J. The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum. 2001, 44(11):2467-2476.
38. Dechend R., Homuth V., Wallukat G., Kreuzer J., Park J.K., Theuer J., et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000, 101(20):2382-2387.
39. Xia Y., Zhou C.C., Ramin S.M., Kellems R.E. Angiotensin receptors, autoimmunity, and preeclampsia. J. Immunol. 2007, 179(6):3391-3395.
40. Zhou C.C., Zhang Y., Irani R.A., Zhang H., Mi T., Popek E.J., et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 2008, 14(8):855-862.
41. Sis B., Einecke G., Chang J., Hidalgo L.G., Mengel M., Kaplan B., et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am. J. Transplant. 2010, 10(2):421-430.
42. [42] Sis B., Jhangri G.S., Riopel J., Chang J., de Freitas D.G., Hidalgo L., et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am. J. Transplant. 2012.
43. Amico P., Honger G., Bielmann D., Lutz D., Garzoni D., Steiger J., et al. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 2008, 85(11):1557-1563.
44. Jordan S.C., Reinsmoen N., Peng A., Lai C.H., Cao K., Villicana R., et al. Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol 2010, 25(10):2035-2048.
45. Bartel G., Schwaiger E., Bohmig G.A. Prevention and treatment of alloantibody-mediated kidney transplant rejection. Transpl. Int. 2011, 24(12):1142-1155.
46. Kelsch R., Everding A.S., Kuwertz-Broking E., Brand E., Spriewald B.M., Sibrowski W., et al. Accelerated kidney transplant rejection and hypertensive encephalopathy in a pediatric patient associated with antibodies against angiotensin type 1 receptor and HLA class II. Transplantation 2011, 92(10):e57-59.
47. Scornik J.C., Guerra G., Schold J.D., Srinivas T.R., Dragun D., Meier-Kriesche H.U. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am. J. Transplant. 2007, 7(7):1808-1814.
48. Billet S., Bardin S., Tacine R., Clauser E., Conchon S. The AT1A receptor " gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II. Am. J. Physiol. Endocrinol. Metab. 2006, 290(5):E840-848.
49. Billet S., Bardin S., Verp S., Baudrie V., Michaud A., Conchon S., et al. Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J. Clin. Invest. 2007, 117(7):1914-1925.
50. Yamani M.H., Cook D.J., Tuzcu E.M., Abdo A., Paul P., Ratliff N.B., et al. Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am. J. Transplant. 2004, 4(7):1097-1102.
51. Yamani M.H., Cook D.J., Rodriguez E.R., Thomas D.M., Gupta S., Alster J., et al. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. J. Heart Lung Transplant. 2006, 25(11):1283-1289.
52. Wu M.S., Yang C.W., Chang C.T., Bens M., Vandewalle A. Cyclosporin increases the density of angiotensin II subtype 1 (AT1) receptors in mouse medullary thick ascending limb cells. Nephrol. Dial Transplant. 2003, 18(8):1458-1465.
53. Nishiyama A., Kobori H., Fukui T., Zhang G.X., Yao L., Rahman M., et al. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 2003, 42(4):754-760.
54. Sodhi C.P., Kanwar Y.S., Sahai A. Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am. J. Physiol. Heart Circ. Physiol. 2003, 284(3):H846-852.
55. Krick S., Hanze J., Eul B., Savai R., Seay U., Grimminger F., et al. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 2005, 19(7):857-859.